Syndax Pharmaceuticals EPS GAAP de -$0.55 fica abaixo em $0.04, receita de $83.3M supera $1.49M

Syndax Pharmaceuticals Q3 earnings: EPS missed, revenue jumped 81.5%, and 2026 expense guidance holds.